Operating profit before deduction of amortization: Revelation Biosciences, Inc. (REVB)
The EBITDA chart for Revelation Biosciences (REVB) illustrates the efficiency of implementing AI models and robotics to digitalize drug development. However, a high dependence on clinical trials and R&D expenditures creates risks where the indicator value reaches 0.00. The company's revenues are based on partnerships and the future sale of treatments for viral infections and kidney pathologies.
Revelation Biosciences, Inc. (REVB) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Revelation Biosciences|REVB - Long-Term Debt to Capital|Current Liabilities to Capital Revelation Biosciences Inc|REVB - Company Debts|Debt to Net Assets Ratio Revelation Biosciences|REVB - Company Long-Term Debts|Short-Term Debt Revelation Biosciences|Quick Liquidity revbiosciences.com
- earnings and multiples data:
REVB - Net Profit|Expected Net Profit Revelation Biosciences|REVB - Price to Earnings Ratio|Future Price to Earnings revbiosciences.com|REVB - PEG Multiple|EV/EBITDA Multiple Revelation Biosciences|REVB - Operating profit before deduction of amortization|Earnings per share for the last four quarters Revelation Biosciences|REVB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months revbiosciences.com|REVB - Earnings per share growth in current year|Expected net earnings per share growth next year Revelation Biosciences
Analysis of all company metrics:Revelation Biosciences Corp
This indicator is calculated as the difference between daily operating income and expenses, reflecting actual cash flow and the scale of current operations. By analyzing the history of operating profit in monetary terms, an investor assesses the commercialization of immune methods at Revelation Biosciences (REVB), where cash flow growth confirms the market penetration of the REVTx-99 drug and the effectiveness of the virus barrier being developed.
Who Revelation Biosciences competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BCRX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization VERA (Vera Corp)|DNTH: Operating profit EBITDA|Profit before interest, taxes and amortization pharvaris.com (PHVS)|Operating profit before deduction of amortization ABCL|Profit before payment of interest, taxes and amortization TRML|Operating profit EBITDA PGEN|PHAR - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Nektar Therapeutics NKTR|upstreambio.com - Profit before payment of interest, taxes and amortization|Zenas Biopharma - Operating profit EBITDA|IMNM - Operating profit EBITDA|GOSS (Gossamer Corp) - Operating profit before deduction of amortization|KALV: Company profit before taxes, interest and amortization|SEPN (Septerna Inc) - Operating profit EBITDA|pieris.com (PVLA) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Savara (SVRA)|RIGL - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization AnaptysBio Corp ANAB|ATXS: Operating profit before amortization|ENGN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization RAPT (RAPT Therapeutics Inc.)|JBIO: Operating profit EBITDA|ACRS (Aclaris Therapeutics Inc.) - Profit before payment of interest, taxes and amortization|KYTX (Kyverna) - Operating profit EBITDA|Tiziana Life Sciences, Ltd. (TLSA) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Cabaletta Bio, Inc. (CABA)|VTYX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Theratechnologies THTX|Operating income before deduction of amortization Avalo Therapeutics, Inc. (AVTX)|Eledon - Operating profit EBITDA|Agenus, Inc (AGEN) - Operating profit before deduction of amortization|CLYM: Operating profit EBITDA|ZURA - Operating income before deduction of amortization|ATYR (aTyr Pharma) - Operating profit EBITDA|Profit before interest, taxes and amortization Adagene Corp ADAG|Profit before payment of interest, taxes and amortization ImageneBio Inc (IMA)|shattucklabs.com - Operating profit before amortization|Operating profit EBITDA EQ (Equillium)|CNTB - Operating profit before deduction of amortization|Immunic Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Atara Biotherapeutics|inflarx.de (IFRX) - Profit before payment of interest, taxes and amortization|XFOR - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Adicet Bio Inc.|CELU: Income before deduction of interest, taxes and amortization|Operating profit EBITDA INMB|BRNS - Profit before interest, taxes and amortization|Kezar Life Sciences, Inc - Operating profit before deduction of amortization|SAB Biotherapeutics Inc - Profit before payment of interest, taxes and amortization|Akari Therapeutics - Operating profit EBITDA|ENLV: Profit before payment of interest, taxes and amortization|q32bio.com (QTTB) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization GOVX (GeoVax Labs)|EDSA (Edesa) - Operating profit EBITDA|IBIO: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CARM|Operating profit EBITDA xtlbio.com (XTLB)|Profit before payment of interest, taxes and amortization Bolt Biotherapeutics, Inc. BOLT|Income before deduction of interest, taxes and amortization HCWB|APVO - Profit before payment of interest, taxes and amortization|AIM ImmunoTech, Inc. (AIM) - Operating profit before deduction of amortization|ADTX: Operating profit EBITDA|gribio.com (GRI) - Operating profit EBITDA|Operating profit before deduction of amortization XRTX|HIND: Income before deduction of interest, taxes and amortization|Operating profit EBITDA INDP|Operating income before deduction of amortization BiondVax Pharmaceuticals|Profit before payment of interest, taxes and amortization CalciMedica CALI|AFMD - Operating profit before deduction of amortization|ALLK - Profit before payment of interest, taxes and amortization|HOOKIPA Pharma Inc. (HOOK) - Operating profit before deduction of amortization|IGMS (igmbio.com) - Operating profit before deduction of amortization|iTeos Pharma (ITOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|Operating profit before amortization TCBP (tcbiopharm.com)|Operating profit EBITDA THRD
